ScinoPharm Taiwan, Ltd (TWSE: 1789), an active pharmaceutical ingredient (API) and formulation specialty company, announced unaudited financial results for its fiscal year 2016.
Effective from November 22, 2016, ScinoPharm (Changshu) Pharmaceuticals, Ltd. has changed its English name to “ SciAnda (Changshu) Pharmaceuticals. Ltd.”.
ScinoPharm Taiwan, Ltd (TWSE: 1789) and CVie Therapeutics Limited (CVie) jointly announced the initiation of a discovery and development collaboration to identify the new generation compound to Istaroxime,
ScinoPharm Taiwan, Ltd (TWSE: 1789), an active pharmaceutical ingredient (API) and formulation specialty company, announced unaudited financial results for its fiscal year 2015.
ScinoPharm (TWSE:1789) today announced that the 6.4-magnitude earthquake struck an area in the island’s southwest at 3:57 a.m. on February 6, 2016 did not cause any personnel injuries nor any structural or facility damage.